Omega Ophthalmics, LLC Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule Toward U.S. Approval
Omega Ophthalmics, LLC today announced the successful close of a $7 million Series A financing and that it has scheduled its FDA pre-submission meeting as the company advances the Gemini Refractive Capsule toward U.S. approval.
Read Article